Haleon Plc (HLN)
9.985
-0.02
(-0.25%)
USD |
NYSE |
Apr 01, 11:29
Haleon Market Cap : 44.46B for April 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GSK Plc | 112.02B |
| Immunocore Holdings Plc | 1.574B |
| Silence Therapeutics Plc | 283.40M |
| Adaptimmune Therapeutics Plc | 5.301M |
| Biodexa Pharmaceuticals Plc | 0.5183M |
Market Cap Related Metrics
| PE Ratio | 20.50 |
| PS Ratio | 3.100 |
| PEG Ratio | 0.2792 |
| Price to Free Cash Flow | 17.49 |
| Price | 9.985 |
| Earnings Yield | 4.88% |
| PEGY Ratio | 0.2724 |
| Operating PE Ratio | 13.79 |
| Normalized PE Ratio | 19.76 |